Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bridgeline Releases "Smart Search" AI Product, Securing Over $60K in ARR
-
Banzai Executes LOI to Acquire Top Rated Lead Generation Platform, IGLeads
-
Form 8.3 - [musicMagpie plc - 04 01 2024] - (CGAML)
-
DZConneX Ranked #1 Overall in HRO Today’s Baker’s Dozen Customer Satisfaction Ratings for Total Workforce Solutions
-
Healthcare Triangle, Inc. to Participate at the 2024 MUSE Executive Institute
-
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
-
Axial Therapeutics to Present at Upcoming Conferences
-
Spero Therapeutics Provides Corporate Update and 2024 Outlook
-
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
-
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
-
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
-
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
-
MAPS Welcomes New Investors, Name Change for MAPS Public Benefit Corporation
-
Pono Capital Three, Inc. Receives Shareholder Approval of the Business Combination with Horizon Aircraft
-
Allegro MicroSystems to Present at Needham’s 26th Annual Growth Conference on January 19
-
WestKam Gold Terminates Acquisition of McConnell Property in British Columbia
-
DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business
-
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
-
Silicon Motion Announces Preliminary Fourth Quarter 2023 Revenue and Earnings Conference Call Details
-
Hurco Reports Fourth Quarter and Full Year Results for Fiscal 2023
-
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Asure Software to Attend 26th Annual Needham Growth Conference
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Midland States Bancorp, Inc. to Announce Fourth Quarter 2023 Financial Results on Thursday, January 25
-
Compass Therapeutics Provides Corporate Update
-
Smart for Life Announces Completion of Audit for Pending Acquisition
-
Stryker to announce financial results for its fourth quarter and full year 2023
-
Greif Announces Price Increase for Uncoated Recycled Paperboard (URB), Tube and Core and Protective Packaging Products
-
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China
-
WiMi Announced Image-Fused Point Cloud Semantic Segmentation with Fusion Graph Convolutional Network
-
CervoMed to Participate in the Emerging Growth Conference 66
-
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
-
First ReWalk Personal Exoskeleton Claim Paid by Medicare
-
Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment
-
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
-
Stryker to announce financial results for its fourth quarter and full year 2023
-
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
-
Fractyl Health Announces Nomination of RJVA-001 as First Clinical Candidate in Its Rejuva® GLP-1 Gene Therapy Platform
-
Constellation Brands Reports Third Quarter Fiscal 2024 Financial Results
-
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
-
Bitech Technologies Receives Initial Purchase Order for its Innovative Energy-Saving VPP Solution to Enter the Building Energy Management System (BEMS) Market
-
RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top Five Best-Selling Master Planned Communities of 2023
-
Alliance Trust PLC - Net Asset Value
-
Pan American Energy Corp Announces Filing of Inaugural NI 43-101 Technical Report For The Horizon Lithium Project
-
Clean Earth Names New Chief Commercial Officer
-
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
-
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
